Back

Survival outcomes of rectal and head and neck cancer patients receiving radio-(chemo)therapy with a ketogenic diet. Results from a controlled clinical study (KETOCOMP)

Klement, R. J.; Sweeney, R. A.

2025-07-23 oncology
10.1101/2025.07.23.25332053 medRxiv
Show abstract

BackgroundHigh-fat, low carbohydrate ketogenic diets (KDs) have been proposed to target the cancer hallmark of high glycolytic metabolism and synergize with radio- and chemotherapy. We here report survival outcomes of rectal and head and neck cancer (HNC) patients who underwent a KD during radio-(chemo)therapy. Materials and MethodsPatients had participated in the controlled KETOCOMP study. The intervention group had consumed a KD during radiotherapy, while the control group had maintained their standard diet. All patients were prospectively followed until the occurrence of disease progression or death to evaluate overall (OS), progression-free (PFS) and locoregional recurrence-free survival (RFS) with the Kaplan-Meier method and by computing restricted mean survival times. In order to simulate a randomized controlled trial and meta-analysis, patients in the KD groups were matched to control patients with propensity score matching and data was pooled. ResultsMedian follow-up was 77.4 (range 12.1-107.9) months (HNC) and 72.6 (16.5-127.1) months (rectal cancer), respectively. HNC patients exhibited non-significantly longer OS and PFS and a trend for longer RFS times (p=0.079). These trends became more pronounced in the propensity score-matched sample (log-rank test p-values <0.10 for all three outcomes). In rectal cancer patients, there was no evidence for a benefit of the KD group. Analysis of the matched and pooled sample revealed a significantly longer restricted mean PFS time in the KD group (p=0.027) and a trend for longer RFS times (p=0.062). OS was also longer in the pooled KD group, but not significantly (p=0.29). ConclusionsThese data indicate the potential for synergistic effects of a KD combined with radio-(chemo)therapy. While sample sizes could have prohibited the observed survival differences from becoming statistically significant, our data are useful to inform future studies or meta-analyses.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.